Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a post on X:
“ASH24.
PrECOG 0905 Gilt vs Mido in ND FLT3m AML at ECOG-ACRIN Cancer Research Group.
PE: mutation MRD -ve composite CR.
Results: cCR was higher with Gilt (85.6 vs 72.4), however cCR with molecular MRD was NS post induction.
Inference: molecular MRD at later time point might worth exploring.”
More posts featuring Talha Badar.
